おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Microbiotica
company
About
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- £50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Dec 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£58M
Microbiotica has raised a total of
£58M
in funding over 2 rounds. Their latest funding was raised on
Feb 7, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 7, 2022 | Series B | £50M | 1 | — | — | Detail |
| Dec 19, 2016 | Seed | £8M | 1 |
Cambridge Innovation Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Microbiotica is funded by 1 investors.
Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cambridge Innovation Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
